23 days ago
mTORC1 drives cell-autonomous astrocyte reactivity in tuberous sclerosis
What's happening
SignalsMonitor is following this as a technology story. Nature is the outlet attached so far. The first report grouped here was at 23 Sept 2026, 16:00 UTC. The headline in use is “mTORC1 drives cell-autonomous astrocyte reactivity in tuberous sclerosis”. This note is SignalsMonitor's own briefing, not the publisher's article.
What we know
Nature, Published online: 23 September 2026; doi:10. 1038/s41586-026-11054-w Reactive astrocytes emerge as a primary consequence of TSC2 loss in tuberous sclerosis complex, implicating glial dysfunction as a primary driver of pathogenesis and highlighting the astrocytes as potential therapeutic targets for tuberous sclerosis complex-related neuropathology.
Story timeline
Reports grouped into this story, earliest first. Exact repeats from the same outlet are collapsed.
- First reported by Nature
mTORC1 drives cell-autonomous astrocyte reactivity in tuberous sclerosis
Reported by 1 outlet
- Nature